期刊文献+

淋巴系统肿瘤并发贫血的研究进展 被引量:1

Advances of the studies on lymphoid neoplasma associated anemia
原文传递
导出
摘要 贫血是淋巴系统肿瘤(LN)常见的并发症之一,影响疾病预后。尽管贫血表象相同,但不同病例可能单独或同时存在失血性贫血、慢性病贫血、自身免疫性溶血性贫血和治疗相关性贫血等。机制各异,治疗方法及侧重点也不尽相同。 Anemia is one of the most common complication and a negative prognostic factor of lymphoid neoplasma. Different cases with lymphoid neoplasma associated anemia (LNAA) have various pathogenesis such as hemorrhagic anemia, anemia of chronic disease, autoimmune hemolytic anemia and treatment related anemia, though they all have the same symptoms. So different regimens are given to different patients according to their pathogenesis of LNAA.
出处 《白血病.淋巴瘤》 CAS 2010年第4期249-253,共5页 Journal of Leukemia & Lymphoma
基金 国家“十一五”科技支撑项目(2008BA161B02) 天津市科技支撑计划重点项目(07ZCGYSF00600)
关键词 淋巴系统 肿瘤 贫血 Lymphoid system Neoplasma Anemia
  • 相关文献

参考文献38

  • 1Ludwig H,Van Belle S,Barrett-Lee P,et al.The European Cancer Anemia Survey (ECAS):a large,multinational,prospective survey defining the prevalence,incidence,and treatment of anemia in cancer patients.Eur J Cancer,2004,40:2293-2306.
  • 2Birgegard G,Gascón P,Ludwig H,et al.Evaluation of anemia in patients with multiple myeloma and lymphoma:findings of the European Cancer Anemia Survey.Eur J Haematol,2006,77:378-386.
  • 3Truong PT,Parhar T,Hart J,et al.A Population-based analysis of the frequency of anemia and its management before and during chemotherapy in patients with malignant lymphoma.Blood (ASH Annual Meeting Abstracts),2006,108:3345.
  • 4Moullet I,Salles G,Ketterer N,et al.Frequency and significance of anemia in non-Hodgkin's lymphoma patients.Ann Oncol,1998,9:1109-1115.
  • 5Kyle RA.Multiple myeloma:review of 869 cases.Mayo Clin Proc,1975,50:29-40.
  • 6Shoji Daigo,Suizu Chizuru,et al.Chemotherapy-induced anemia in lymphoma patients.Hematol & Oncol,2006,52:216-225.
  • 7Ludwig H,Van Belle S,Barrett-Lee P,et al.The european cancer anaemia surrey (ECAS):a large,multinational.Prospective survey defining the prevalence,incidence and treatment of anaemia in cancer patients.Eur J Cancer,2004,40:2293-2306.
  • 8Ludwiczek S,Aigner E,Theurl I,et al.Cytokine2mediated regulation of iron transport in human monocytic cells.Blood,2003,101:4148-4154.
  • 9Faulds D,Sorkin EM.Epoetin (recombinant human erythropoietin).A review of its pharmacodynamic and pharmacokinetic properties and therapeutic potential in anaemia and the stimulation of erythropoieais.Drugs,1989,38:863-899.
  • 10Shen T,Shi Y,Zhu J,et al.Erythropoietin response to anemia is impaired in patients with hematologic malignancies.Blood,2005,106:3744.

二级参考文献10

  • 1Koopman G, Reutelingsperger CP, Kuijten GA, et al. Annexin V for flow cytometric detection of phosphatidylserine expression on B cells undergoing apoptosis. Blood, 1994,84 : 1415-1420.
  • 2Gerdes J ,Schwab U ,Lemke H ,et al. Production of a mouse monoclonal antibody reactive with a human nuclear antigen association with cell proliferation. Int J cancer. 1983 ;31:13-20.
  • 3Miller JL, Njoroge JM, Gubin AN, et al. Prospective identification of erythroid elements in cultured peripheral blood. Exp Hematol, 1999,27 :624-629.
  • 4Olesen G, Carlsen I, Skovbo A, et al. Delineation of erythropoiesis in normal and malignant bone marrow using monoclonal antibody AS-E1 directed against transferring receptors (CD71). Eur J Haematol, 1998,60:53-60.
  • 5Wojda U, Noel P, Miller JL. Fetal and adult hemoglobin production during adult erythropoiesis : coordinate expression correlates with cell proliferation. Blood,2002,99:3005-3013.
  • 6Papadaki HA, Kritikos HD, Valalis V, et al. Anemia of chronic disease in rheumatoid arthritis is associated with increased apoptosis of bone marrow erythroid cells : improvement following anti-tumor necrosis factor-αantibody therapy. Blood ,2002,100:474-482.
  • 7Shinjo K, Takeshita A, Higuchi M, et al. Erythroietin receptor expression on human bone marrow erythroid precursor cells : a newly-devised quantitative flow-cytometric assay. Br J Haematol, 1997,96 : 551-558.
  • 8Ludwig H. Anemia of hematologic malignancies. Semin Onco1,2002 ,29( Suppl 8) :44-54.
  • 9Samol J, Littlewood TJ. The efficacy of rHuEPO in cancer-related anemia. Br J Haematol.2003.121,3-11.
  • 10Weiss MJ. New insights into erythropoietin and epoetin alfa:mechanisms of action, target tissues, and clinical applications. The Oncologist ,2003,8 ( suppl 3 ) : 18-29.

共引文献3

同被引文献6

  • 1张亚平 钱思轩 李建勇.慢性淋巴细胞白血病的自身免疫性疾病研究进展.国际输血及血液学杂志,2008,.
  • 2The European Cancer Anaemia Survey (ECAS): a large, multinational, prospective survey defining the prevalence, incidence, and treatment of anaemia in cancer patients. Eur J Cancer, 2004,40(15) : 2293-2306.
  • 3Mauro FR, Foa R, Cerretti R, et al. Autoimmune hemolytic anemia in chronic lymphocytic leukemia: clinical, therapeutic, and prognostic features. Blood, 2000,95 (9) : 2786-2792.
  • 4Hauswirth AW,Skrahs C,Schtitzinger C. Autoimmune hemolytic attemta, Evans syndrome,and pure red cell aplasia in non-Hodgkin lymphoma. Leuk Lymphoma,2007,48(6) :1139-1149.
  • 5何婉,王季石,孙志强,刘丽,卢英豪,谢润兰,熊玉芝.非霍奇金淋巴瘤并发自身免疫性溶血性贫血及纯红细胞再生障碍性贫血二例[J].中华内科杂志,2008,47(6):508-509. 被引量:4
  • 6陈岳华.以自身免疫性溶血性贫血首发的恶性淋巴瘤长期误诊一例[J].实用肿瘤杂志,2000,15(5):325-325. 被引量:2

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部